Latest Treatment For Low Testosterone News

Stocks to Watch: Tesla, Facebook, Safeway
Antares Pharma Inc. on Thursday said its Vibex QuickShot treatment for low testosterone showed positive results in a Phase 2 trial. Shares of the company, which produces injector technologies for the drug industry, rose 3% to $ 4.83 in premarket trading.
Read more on Wall Street Journal (blog)